Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
- PMID: 34846211
- PMCID: PMC8647220
- DOI: 10.1177/10760296211051708
Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
Abstract
Carotid and vertebral artery dissections are estimated to account for ∼20% of strokes in patients under 45-years-old. This meta-analysis compared the efficacy and safety of treatment with anticoagulants versus antiplatelet agents to determine the optimal therapy. We searched 4 electronic databases for clinical trials published from January 1, 1980 to August 25, 2021 that included patients who received anticoagulant or antiplatelet therapy for carotid and/or vertebral artery dissections. The curative effect was judged by recanalization evaluated by imaging. The primary outcomes were all cause death and ischemic stroke; secondary outcomes included hemorrhage and transient ischemic attack (TIA). Patients who received only a single drug treatment were divided into antiplatelet or anticoagulant groups; all received conservative treatment without surgical intervention. For this investigation, we pooled the available studies to conduct a meta-analysis, which included 7 articles with 1126 patients. The curative effect of vascular recanalization was not significantly different between the 2 treatment groups (odds ratio [OR] = 0.913, 95% confidence interval [CI]: 0.611-1.365, P = .657); similarly, no significant differences were found regarding the primary outcomes all cause death (OR = 1.747, 95%CI: 0.202-15.079, P = .612) and ischemic stroke (OR = 2.289, 95%CI: 0.997-5.254, P = .051). Patients treated with anticoagulants were more likely to experience TIA (OR = 0.517, 95%CI: 0.252-1.060, P = .072) and hemorrhage (OR = 0.468, 95%CI: 0.210-1.042, P = .063), but the differences were not statistically significant. Overall, there were no statistically significant differences between anticoagulant therapy and antiplatelet therapy for the treatment of carotid and vertebral artery dissections.
Keywords: anticoagulant; antiplatelet; carotid artery dissection; stroke; vertebral artery dissection.
Conflict of interest statement
Figures






Similar articles
-
Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.Cerebrovasc Dis. 2014;38(4):247-53. doi: 10.1159/000366265. Epub 2014 Nov 13. Cerebrovasc Dis. 2014. PMID: 25401389
-
Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.Lancet Neurol. 2015 Apr;14(4):361-7. doi: 10.1016/S1474-4422(15)70018-9. Epub 2015 Feb 12. Lancet Neurol. 2015. PMID: 25684164 Clinical Trial.
-
Early Anticoagulation or Antiplatelet Therapy Is Critical in Craniocervical Artery Dissection: Results from the COMPASS Registry.Cerebrovasc Dis. 2020;49(4):369-374. doi: 10.1159/000509415. Epub 2020 Jul 30. Cerebrovasc Dis. 2020. PMID: 32731249
-
Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis.Neurology. 2012 Aug 14;79(7):686-9. doi: 10.1212/WNL.0b013e318264e36b. Epub 2012 Aug 1. Neurology. 2012. PMID: 22855862 Clinical Trial.
-
Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis.JAMA Neurol. 2024 Jun 1;81(6):630-637. doi: 10.1001/jamaneurol.2024.1141. JAMA Neurol. 2024. PMID: 38739383 Free PMC article.
Cited by
-
Vitamin K antagonist versus novel oral anticoagulants for management of cervical artery dissection: Interactive systematic review and meta-analysis.Eur Stroke J. 2022 Dec;7(4):349-357. doi: 10.1177/23969873221111051. Epub 2022 Jul 6. Eur Stroke J. 2022. PMID: 36478754 Free PMC article.
-
Intravenous cangrelor infusion for the treatment of traumatic intracranial internal carotid artery dissection: illustrative case.J Neurosurg Case Lessons. 2025 Jun 30;9(26):CASE2559. doi: 10.3171/CASE2559. Print 2025 Jun 30. J Neurosurg Case Lessons. 2025. PMID: 40587894 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical